1. Home
  2. SLGL vs KBSX Comparison

SLGL vs KBSX Comparison

Compare SLGL & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • KBSX
  • Stock Information
  • Founded
  • SLGL 1997
  • KBSX 1976
  • Country
  • SLGL Israel
  • KBSX Taiwan
  • Employees
  • SLGL N/A
  • KBSX N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • KBSX Recreational Games/Products/Toys
  • Sector
  • SLGL Health Care
  • KBSX Consumer Discretionary
  • Exchange
  • SLGL Nasdaq
  • KBSX Nasdaq
  • Market Cap
  • SLGL 69.1M
  • KBSX 74.8M
  • IPO Year
  • SLGL 2018
  • KBSX N/A
  • Fundamental
  • Price
  • SLGL $29.01
  • KBSX $1.49
  • Analyst Decision
  • SLGL
  • KBSX
  • Analyst Count
  • SLGL 0
  • KBSX 0
  • Target Price
  • SLGL N/A
  • KBSX N/A
  • AVG Volume (30 Days)
  • SLGL 25.3K
  • KBSX 21.0K
  • Earning Date
  • SLGL 08-15-2025
  • KBSX 08-21-2025
  • Dividend Yield
  • SLGL N/A
  • KBSX N/A
  • EPS Growth
  • SLGL N/A
  • KBSX N/A
  • EPS
  • SLGL N/A
  • KBSX N/A
  • Revenue
  • SLGL $23,931,000.00
  • KBSX $40,863,331.00
  • Revenue This Year
  • SLGL N/A
  • KBSX N/A
  • Revenue Next Year
  • SLGL $31.17
  • KBSX N/A
  • P/E Ratio
  • SLGL N/A
  • KBSX N/A
  • Revenue Growth
  • SLGL 264.86
  • KBSX 20.42
  • 52 Week Low
  • SLGL $4.01
  • KBSX $1.26
  • 52 Week High
  • SLGL $30.98
  • KBSX $15.48
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 65.45
  • KBSX 28.99
  • Support Level
  • SLGL $23.15
  • KBSX $1.41
  • Resistance Level
  • SLGL $30.98
  • KBSX $1.67
  • Average True Range (ATR)
  • SLGL 2.27
  • KBSX 0.05
  • MACD
  • SLGL 0.00
  • KBSX -0.01
  • Stochastic Oscillator
  • SLGL 74.90
  • KBSX 30.50

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

Share on Social Networks: